TELA Bio (TELA) Competitors $1.00 +0.03 (+3.09%) Closing price 04:00 PM EasternExtended Trading$1.01 +0.01 (+1.00%) As of 04:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TELA vs. ZJYL, PROF, AVR, LUCD, OBIO, INFU, KRMD, SKIN, MGRM, and ICADShould you be buying TELA Bio stock or one of its competitors? The main competitors of TELA Bio include Jin Medical International (ZJYL), Profound Medical (PROF), Anteris Technologies Global (AVR), Lucid Diagnostics (LUCD), Orchestra BioMed (OBIO), InfuSystem (INFU), KORU Medical Systems (KRMD), Beauty Health (SKIN), Monogram Orthopaedics (MGRM), and iCAD (ICAD). These companies are all part of the "medical equipment" industry. TELA Bio vs. Jin Medical International Profound Medical Anteris Technologies Global Lucid Diagnostics Orchestra BioMed InfuSystem KORU Medical Systems Beauty Health Monogram Orthopaedics iCAD Jin Medical International (NASDAQ:ZJYL) and TELA Bio (NASDAQ:TELA) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, analyst recommendations, profitability, institutional ownership, dividends, community ranking, media sentiment and valuation. Does the MarketBeat Community believe in ZJYL or TELA? TELA Bio received 60 more outperform votes than Jin Medical International when rated by MarketBeat users. CompanyUnderperformOutperformJin Medical InternationalN/AN/ATELA BioOutperform Votes6074.07% Underperform Votes2125.93% Which has more volatility and risk, ZJYL or TELA? Jin Medical International has a beta of 12.28, suggesting that its stock price is 1,128% more volatile than the S&P 500. Comparatively, TELA Bio has a beta of 0.98, suggesting that its stock price is 2% less volatile than the S&P 500. Is ZJYL or TELA more profitable? Jin Medical International has a net margin of 0.00% compared to TELA Bio's net margin of -60.49%. Jin Medical International's return on equity of 0.00% beat TELA Bio's return on equity.Company Net Margins Return on Equity Return on Assets Jin Medical InternationalN/A N/A N/A TELA Bio -60.49%-556.18%-63.13% Do analysts prefer ZJYL or TELA? TELA Bio has a consensus target price of $7.25, suggesting a potential upside of 625.00%. Given TELA Bio's stronger consensus rating and higher probable upside, analysts plainly believe TELA Bio is more favorable than Jin Medical International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jin Medical International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00TELA Bio 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Which has better valuation & earnings, ZJYL or TELA? Jin Medical International has higher earnings, but lower revenue than TELA Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJin Medical International$23.50M5.33$3.68MN/AN/ATELA Bio$69.30M0.57-$46.66M-$1.39-0.72 Do institutionals and insiders hold more shares of ZJYL or TELA? 94.3% of TELA Bio shares are held by institutional investors. 6.0% of TELA Bio shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media prefer ZJYL or TELA? In the previous week, Jin Medical International had 1 more articles in the media than TELA Bio. MarketBeat recorded 3 mentions for Jin Medical International and 2 mentions for TELA Bio. TELA Bio's average media sentiment score of 1.43 beat Jin Medical International's score of 0.96 indicating that TELA Bio is being referred to more favorably in the news media. Company Overall Sentiment Jin Medical International Positive TELA Bio Positive SummaryTELA Bio beats Jin Medical International on 8 of the 15 factors compared between the two stocks. Get TELA Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TELA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TELA vs. The Competition Export to ExcelMetricTELA BioSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$39.56M$4.33B$5.53B$7.93BDividend YieldN/A39.93%5.11%4.22%P/E Ratio-0.5930.0322.5118.54Price / Sales0.5755.31397.62103.30Price / CashN/A51.0838.1834.62Price / Book1.306.056.734.25Net Income-$46.66M$68.71M$3.22B$248.18M7 Day Performance2.88%0.05%1.58%1.25%1 Month Performance-21.26%-2.15%4.05%3.76%1 Year Performance-78.40%22.61%15.75%5.28% TELA Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TELATELA Bio2.9792 of 5 stars$1.00+3.1%$7.25+625.0%-78.5%$39.56M$69.30M-0.59120Upcoming EarningsShort Interest ↓ZJYLJin Medical InternationalN/A$0.89-5.3%N/A-76.1%$139.33M$23.50M0.00245PROFProfound Medical2.2385 of 5 stars$4.56-4.6%$14.25+212.5%-32.9%$136.98M$10.68M-3.40150Upcoming EarningsNews CoverageAVRAnteris Technologies GlobalN/A$3.14+9.0%$16.50+425.5%N/A$113.12M$2.71M0.00138News CoveragePositive NewsLUCDLucid Diagnostics2.4586 of 5 stars$1.20-0.8%$3.50+191.7%+38.7%$108.91M$4.35M-1.0570OBIOOrchestra BioMed2.7744 of 5 stars$2.84-0.4%$15.00+428.2%-32.7%$108.81M$2.64M-1.764News CoverageGap DownINFUInfuSystem1.4964 of 5 stars$4.91flat$13.00+164.8%-37.2%$103.19M$134.86M81.85410KRMDKORU Medical Systems3.2485 of 5 stars$2.24-1.3%$4.70+109.8%+26.7%$102.94M$33.65M-8.9680Upcoming EarningsNews CoveragePositive NewsSKINBeauty Health2.0018 of 5 stars$0.82-2.9%$2.50+204.4%-69.3%$102.86M$334.29M-1.961,030Upcoming EarningsNews CoverageMGRMMonogram Orthopaedics2.4578 of 5 stars$2.65-1.9%$5.40+103.8%+47.7%$93.52M$364,999.00-5.6428ICADiCAD0.5751 of 5 stars$3.03-5.9%N/A+139.2%$82.92M$19.61M-23.31140Gap DownHigh Trading Volume Related Companies and Tools Related Companies Jin Medical International Competitors Profound Medical Competitors Anteris Technologies Global Competitors Lucid Diagnostics Competitors Orchestra BioMed Competitors InfuSystem Competitors KORU Medical Systems Competitors Beauty Health Competitors Monogram Orthopaedics Competitors iCAD Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TELA) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored"I'm risking my reputation on this"I've stayed quiet for too long, but after everything I've uncovered about what's brewing in the 2025 crypto ma...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TELA Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TELA Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TELA Stock Free TELA Stock Alerts